Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1 -/-.IL-2rγc -/- mice

Human Gene Therapy

Volumn 22, Issue 10, 2011, Pages 1209-1224

  Salguero, Gustavo ^a   Sundarasetty, Bala Sai ^a   Borchers, Sylvia ^a   Wedekind, Dirk ^a   Eiz Vesper, Britta ^a   Velaga, Sarvari ^a   Jirmo, Adan C ^a   Behrens, Georg ^a   Warnecke, Gregor ^a   Knöfel, Ann Kathrin ^a   Blasczyk, Rainer ^a   Mischak Weissinger, Eva ^a   Ganser, Arnold ^a   Stripecke, Renata ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LENTIVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOTRANSPLANTATION; BLOOD CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; DONOR; EFFECTOR CELL; EX VIVO GENE TRANSFER; GENE TRANSFER; HOMEOSTASIS; HUMAN; HUMAN CELL; IMAGING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; IN VIVO STUDY; INFUSION; MONOCYTE; MOUSE; NONHUMAN; ORGAN; SPLEEN; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; GENES, RAG-1; GENETIC VECTORS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LENTIVIRUS; LYMPHOPENIA; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MONOCYTES; OPPORTUNISTIC INFECTIONS; PHOSPHOPROTEINS; TRANSDUCTION, GENETIC; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 5; MUS;

EID: 80155139476     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.215     Document Type: Article

References (28)

1. Anthony, D.D., Yonkers, N.L., Post, A.B., et al. (2004). Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 172, 4907-4916. (Pubitemid 38456415)
2. Borst, E.M., Benkartek, C., and Messerle, M. (2007). Use of bacterial artificial chromosomes in generating targeted mutations in human and mouse cytomegaloviruses. Curr. Protoc. Immunol. Chapter 10, Unit 10 32.
3. De Vries, I.J., Krooshoop, D.J., Scharenborg, N.M., et al. (2003). Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63, 12-17. (Pubitemid 36070411)
4. Figdor, C.G., De Vries, I.J., Lesterhuis, W.J., and Melief, C.J. (2004). Dendritic cell immunotherapy: mapping the way. Nat. Med. 10, 475-480. (Pubitemid 38667904)
5. Gorantla, S., Santos, K., Meyer, V., et al. (2005). Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge. J. Virol. 79, 2124-2132. (Pubitemid 40204570)
6. Harui, A., Kiertscher, S.M., and Roth, M.D. (2011). Reconstitution of huPBL-Nsg mice with donor-matched dendritic cells enables antigen-specific T-cell activation. J. Neuroimmune Pharmacol. 6, 148-157.
7. Horvath, R., Budinsky, V., Kayserova, J., et al. (2009). Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease. Clin. Immunol. 131, 60-69.
8. Inoue, M., Senju, S., Hirata, S., et al. (2009). An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/ Shi-scid IL2rgamma(null) (NOG) mice. Immunol. Lett. 126, 67-72.
9. Kimura, T., Koya, R.C., Anselmi, L., et al. (2007). Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression. Mol. Ther. 15, 1390-1399. (Pubitemid 46965335)
10. Kolb, H.J. (2008). Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 112, 4371-4383.
11. Korin, Y.D., and Zack, J.A. (1998). Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72, 3161-3168. (Pubitemid 28175559)
12. Koya, R.C., Weber, J.S., Kasahara, N., et al. (2004). Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14 + monocytes generates dendritic cells in vitro. Hum. Gene Ther. 15, 733-748. (Pubitemid 39095246)
13. Koya, R.C., Kimura, T., Ribas, A., et al. (2007). Lentiviral vectormediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines. Mol. Ther. 15, 971-980. (Pubitemid 46621656)
14. Lacey, S.F., Villacres, M.C., La Rosa, C., et al. (2003). Relative dominance of HLA-Bz.ast;07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-Az.ast;02 and HLA-Bz.ast;07 alleles. Hum. Immunol. 64, 440-452. (Pubitemid 36373774)
15. Lapenta, C., Santini, S.M., Spada, M., et al. (2006). IFN-alphaconditioned dendritic cells are highly efficient in inducing cross-priming CD8( + ) T cells against exogenous viral antigens. Eur. J. Immunol. 36, 2046-2060. (Pubitemid 44251751)
16. Maurice, M., Verhoeyen, E., Salmon, P., et al. (2002). Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cellactivating polypeptide. Blood 99, 2342-2350. (Pubitemid 34525419)
17. Merad, M., and Manz, M.G. (2009). Dendritic cell homeostasis. Blood 113, 3418-3427.
18. Pearson, T., Shultz, L.D., Miller, D., et al. (2008). Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin. Exp. Immunol. 154, 270-284.
19. Pincha, M., Sundarasetty, B.S., and Stripecke, R. (2010). Lentiviral vectors for immunization: an inflammatory field. Expert Rev. Vaccines 9, 309-321.
20. Pincha, M., Salguero, G., Wedekind, D., et al. (2011). Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells. Gene Ther. Mar 17. [Epub ahead of print] PubMed PMID: 21412283.
21. Small, T.N., Papadopoulos, E.B., Boulad, F., et al. (1999). Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 93, 467-480. (Pubitemid 29035728)
22. Stripecke, R. (2009). Lentiviral vector-mediated genetic programming of mouse and human dendritic cells. Methods Mol. Biol. 506, 139-158.
23. Sylwester, A.W., Mitchell, B.L., Edgar, J.B., et al. (2005). Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202, 673-685. (Pubitemid 41248418)
24. Szymczak, A.L., and Vignali, D.A. (2005). Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin. Biol. Ther. 5, 627-638. (Pubitemid 40780547)
25. Szymczak, A.L., Workman, C.J., Wang, Y., et al. (2004). Correction of multi-gene deficiency in vivo using a single 'selfcleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589-594. (Pubitemid 38585911)
26. Williams, K.M., Hakim, F.T., and Gress, R.E. (2007). T cell immune reconstitution following lymphodepletion. Semin. Immunol. 19, 318-330. (Pubitemid 350181530)
27. Yamashita, K., Choi, U., Woltz, P.C., et al. (2004). Severe chronic graft-versus-host disease is characterized by a preponderance of CD4( + ) effector memory cells relative to central memory cells. Blood 103, 3986-3988. (Pubitemid 38596324)
28. Yoshida, A., Tanaka, R., Murakami, T., et al. (2003). Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-Scid mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4( +) Tcell origin. J. Virol. 77, 8719-8728. (Pubitemid 36936083)